New drug Kylo-12 takes first step in human trials for high fat levels in blood
NCT ID NCT06783881
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 26 times
Summary
This early-stage study tests a new medicine called Kylo-12 in about 50 healthy people with high triglycerides (a type of fat in the blood). The main goal is to check safety and how the body handles the drug. Researchers will also look at how it affects fat levels over time. This is the first time Kylo-12 is given to humans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chengdu Xinhua Hospital
Chengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.